TD Asset Management Portfolio holdings
AUM
$117B
1-Year Return
25.17%
This Quarter Return
-15.11%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$86.3B
AUM Growth
-$23B
(-21%)
Cap. Flow
-$4.26B
Cap. Flow
% of AUM
-4.93%
Top 10 Holdings %
Top 10 Hldgs %
27.54%
Holding
1,538
New
56
Increased
352
Reduced
823
Closed
81
Top Buys
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$304M |
| 2 |
UnitedHealth
UNH
|
+$146M |
| 3 |
Northrop Grumman
NOC
|
+$137M |
| 4 |
Stryker
SYK
|
+$118M |
| 5 |
Tesla
TSLA
|
+$110M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.63B |
| 2 |
Financial Select Sector SPDR Fund
XLF
|
+$381M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$245M |
| 4 |
Meta Platforms (Facebook)
META
|
+$243M |
| 5 |
Comcast
CMCSA
|
+$141M |
Sector Composition
| 1 | Financials | 20.11% |
| 2 | Technology | 17.74% |
| 3 | Healthcare | 10.68% |
| 4 | Consumer Discretionary | 8.17% |
| 5 | Communication Services | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Copart
CPRT
$46.7B
| $18.2M | 0.02% |
670,720
+49,500
| +8% | +$1.34M |
|
452
Ultragenyx Pharmaceutical
RARE
$3.04B
| $18.2M | 0.02% |
304,227
-54,114
| -15% | -$3.23M |
|
453
DexCom
DXCM
$30.3B
| $18.1M | 0.02% |
242,466
-2,002
| -0.8% | -$149K |
|
454
Norfolk Southern
NSC
$61.4B
| $18M | 0.02% |
79,180
-2,640
| -3% | -$600K |
|
455
Sun Communities
SUI
$16.3B
| $18M | 0.02% |
112,830
-2,135
| -2% | -$340K |
|
456
Steris
STE
$24.4B
| $18M | 0.02% |
87,194
-17,682
| -17% | -$3.65M |
|
457
Alexandria Real Estate Equities
ARE
$14.4B
| $17.9M | 0.02% |
123,395
-78,590
| -39% | -$11.4M |
|
458
Markel Group
MKL
$24.5B
| $17.8M | 0.02% |
13,741
-433
| -3% | -$560K |
|
459
General Dynamics
GD
$86.8B
| $17.7M | 0.02% |
79,796
-1,854
| -2% | -$410K |
|
460
Marathon Petroleum
MPC
$56B
| $17.6M | 0.02% |
214,660
-21,605
| -9% | -$1.78M |
|
461
Illumina
ILMN
$15.2B
| $17.6M | 0.02% |
98,227
-1,533
| -2% | -$275K |
|
462
ResMed
RMD
$39.7B
| $17.4M | 0.02% |
83,083
-5,816
| -7% | -$1.22M |
|
463
Parker-Hannifin
PH
$96.9B
| $17.2M | 0.02% |
69,935
+8,899
| +15% | +$2.19M |
|
464
Bunge Global
BG
$16.4B
| $17.2M | 0.02% |
189,399
+21,895
| +13% | +$1.99M |
|
|
GTPB
465
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
| $17.1M | 0.02% |
1,750,000
| – | – |
|
466
Reynolds Consumer Products
REYN
$4.79B
| $17.1M | 0.02% |
626,200
-15,800
| -2% | -$431K |
|
|
KVSC
467
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
| $17M | 0.02% |
1,750,000
| – | – |
|
468
Labcorp
LH
$23B
| $17M | 0.02% |
84,391
-8,670
| -9% | -$1.75M |
|
469
Nexstar Media Group
NXST
$6.01B
| $16.9M | 0.02% |
103,985
+30,361
| +41% | +$4.95M |
|
470
Idexx Laboratories
IDXX
$52.1B
| $16.9M | 0.02% |
48,271
-1,626
| -3% | -$570K |
|
471
Manhattan Associates
MANH
$13.1B
| $16.9M | 0.02% |
147,627
+3,620
| +3% | +$415K |
|
472
Sempra
SRE
$52.7B
| $16.9M | 0.02% |
225,058
-11,410
| -5% | -$857K |
|
473
Allstate
ALL
$52.8B
| $16.9M | 0.02% |
133,335
-73,000
| -35% | -$9.25M |
|
474
T Rowe Price
TROW
$23.6B
| $16.8M | 0.02% |
148,071
-23,213
| -14% | -$2.64M |
|
475
Moody's
MCO
$91.5B
| $16.8M | 0.02% |
61,842
-1,521
| -2% | -$414K |
|